Organogenesis Holdings Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 0.8189 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 105.37M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers ...